Home › Stocks › CPRX › All Fund Holders
CPRX — CATALYST PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 44 · Reported value held: $1.67B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 19.16M | $602.16M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 8.43M | $196.81M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 3.17M | $99.89M | 0.01% | New |
| Geode Capital Management history | Q2 2026 | 3.15M | $99.03M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 2.76M | $86.76M | 0.01% | Add |
| Renaissance Technologies history | Q2 2026 | 2.14M | $67.14M | 0.09% | Reduce |
| Janus Henderson Group history | Q1 2026 | 2.00M | $49.52M | 0.03% | Add |
| UBS Group AG history | Q2 2026 | 1.45M | $45.69M | 0.01% | Add |
| Northern Trust Corp history | Q2 2026 | 1.33M | $41.82M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 1.31M | $41.22M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 1.19M | $37.53M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 1.16M | $36.44M | 0.01% | Reduce |
| Millennium Management history | Q2 2026 | 1.07M | $33.59M | 0.01% | Add |
| Marshall Wace history | Q2 2026 | 911.70K | $28.65M | 0.02% | Add |
| Arrowstreet Capital history | Q2 2026 | 748.92K | $23.54M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 703.23K | $22.10M | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 683.27K | $21.48M | 0.01% | Add |
| Fidelity International (FIL) history | Q2 2026 | 650.00K | $20.43M | 0.01% | New |
| Invesco Ltd history | Q2 2026 | 445.99K | $14.02M | 0.00% | Reduce |
| PSP Investments history | Q2 2026 | 395.19K | $12.42M | 0.03% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 360.47K | $11.33M | 0.00% | Add |
| Royce & Associates history | Q2 2026 | 358.64K | $11.27M | 0.09% | Reduce |
| Soros Fund Management history | Q2 2026 | 344.59K | $10.83M | 0.15% | New |
| Legal & General Investment Management America history | Q2 2026 | 275.51K | $8.66M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 186.87K | $5.87M | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 176.56K | $5.55M | 0.01% | Reduce |
| Citigroup Inc history | Q2 2026 | 136.67K | $4.30M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 134.53K | $4.23M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 130.23K | $4.09M | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 119.97K | $3.77M | 0.00% | Reduce |
| Franklin Resources history | Q2 2026 | 119.52K | $3.76M | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 96.65K | $3.04M | 0.00% | Reduce |
| Manulife Financial history | Q2 2026 | 59.28K | $1.86M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 56.60K | $1.78M | 0.00% | Reduce |
| Wellington Management Group history | Q1 2026 | 46.82K | $1.16M | 0.00% | Reduce |
| Amundi US history | Q2 2026 | 33.56K | $1.05M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 30.35K | $954.03K | 0.00% | New |
| MFS Investment Management history | Q1 2026 | 36.84K | $912.18K | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2024 | 51.81K | $802.61K | 0.00% | New |
| Lazard Asset Management history | Q2 2026 | 17.29K | $543.52K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 14.30K | $449.45K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 10.95K | $344.19K | 0.00% | Add |
| Norges Bank Investment Management history | Q2 2025 | 13.77K | $298.72K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 158.61K | $4.99K | 0.00% | Reduce |